Evidence map›Paper›PMID 30925808›Full record

ArticleInternational journal of molecular sciences2019

miR-31-5p Is a LIPUS-Mechanosensitive MicroRNA that Targets HIF-1α Signaling and Cytoskeletal Proteins.

Viviana Costa, Valeria Carina, Alice Conigliaro, Lavinia Raimondi, Angela De Luca, Daniele Bellavia, Francesca Salamanna, Stefania Setti, Riccardo Alessandro, Milena Fini and 1 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04851210 completednot on this mapstarted 2022, after this paper: background citation

Identification of miRNAs Associated With Gender Difference in Osteoarthritis Patients

TypeobservationalSponsorIstituto Ortopedico RizzoliRan2022 to 2024Enrolled13ConditionsOsteoarthritisArmsNo intervention
NCT06040957 narecruitingnot on this mapstarted 2024, after this paper: background citation

Bone Marrow vs Adipose Tissue as a Cell Source for Infiltrative Treatment of Knee Osteoarthritis: Randomized Clinical Trial

TypeinterventionalSponsorIstituto Ortopedico RizzoliRan2024 to 2027Enrolled204ConditionsKnee OsteoarthritisArmsBone marrow aspirate concentrate injection, intra-articular injection of Minimally manipulated adipose tissue
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Hypoxia Pathway in Osteoporosis: Laboratory Data for Clinical Prospects.International journal of environmental research and public health · 2023
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Viviana CostaIRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy. viviana.costa@ior.it.ORCID 0000-0002-2425-6460
Valeria CarinaIRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy. valeria.carina@ior.it.ORCID 0000-0002-7323-8023
Alice ConigliaroDepartment of BioMedicine, Neuroscience and Advanced Diagnostics (Bi.N.D), University of Palermo, 90100 Palermo, Italy. alice.conigliaro@unipa.it.ORCID 0000-0002-3037-835X
Lavinia RaimondiIRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy. lavinia.raimondi@ior.it.ORCID 0000-0001-9394-2002
Angela De LucaIRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy. angela.deluca@ior.it.
Daniele BellaviaIRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy. daniele.bellavia@ior.it.ORCID 0000-0003-3308-9112
Francesca SalamannaIRCCS Istituto Ortopedico Rizzoli, Laboratory of Preclinical and Surgical Studies, 40136 Bologna, Italy. francesca.salamanna@ior.it.
Stefania SettiIGEA SpA, 41012 Carpi (Modena), Italy. s.setti@igeamedical.com.ORCID 0000-0001-8990-5452
Riccardo AlessandroDepartment of BioMedicine, Neuroscience and Advanced Diagnostics (Bi.N.D), University of Palermo, 90100 Palermo, Italy. riccardo.alessandro@unipa.it.ORCID 0000-0002-9935-1040
Milena FiniIRCCS Istituto Ortopedico Rizzoli, Laboratory of Preclinical and Surgical Studies, 40136 Bologna, Italy. milena.fini@ior.it.
Gianluca GiavaresiIRCCS Istituto Ortopedico Rizzoli, Laboratory of Preclinical and Surgical Studies, 40136 Bologna, Italy. gianluca.giavaresi@ior.it.ORCID 0000-0001-7843-5969
Istituto Ortopedico Rizzoli · ITInterventi Geo Ambientali (Italy) · ITIstituto di Biomedicina e di Immunologia Molecolare Alberto Monroy · ITUniversity of Palermo · IT

Funding

Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) MFAG 2017 Id.19982Operative Program for Research and Competitiveness 2007-2013 PON03_00011 "Potenziamento strutturale di una rete di eccellenza per la ricerca preclinica e clinica sulla terapia personalizzata in oncologia e in medicina rigenerativa".
6 · The paper itself

Abstract

The roles of low-intensity pulsed ultrasound (LIPUS) and microRNAs (miRNAs) on hMSCs commitments have already been investigated; however, the effects of the application of their co-treatments in an in vitro cell model are still unknown. Our previous studies demonstrated that (i) LIPUS modulated hMSCs cytoskeletal organization and (ii) miRNA-675-5p have a role in HIF-1α signaling modulation during hMSCs osteoblast commitment. We investigated for the first time the role of LIPUS as promoter tool for miRNA expression. Thanks to bioinformatic analysis, we identified miR-31-5p as a LIPUS-induced miRNA and investigated its role through in vitro studies of gain and loss of function. Results highlighted that LIPUS stimulation induced a hypoxia adaptive cell response, which determines a reorganization of cell membrane and cytoskeleton proteins. MiR-31-5p gain and loss of function studies, demonstrated as miR-31-5p overexpression, were able to induce hypoxic and cytoskeletal responses. Moreover, the co-treatments LIPUS and miR-31-5p inhibitor abolished the hypoxic responses including angiogenesis and the expression of Rho family proteins. MiR-31-5p was identified as a LIPUS-mechanosensitive miRNAs and may be considered a new therapeutic option to promote or abolish hypoxic response and cytoskeletal organization on hMSCs during the bone regeneration process.

Indexed as

Ultrasonic WavesCell DifferentiationCell LineCytoskeletal ProteinsHumansHypoxia-Inducible Factor 1, alpha SubunitMesenchymal Stem CellsMicroRNAsOsteoblastsUp-RegulationCytoskeletal ProteinsHypoxia-Inducible Factor 1, alpha SubunitMicroRNAsMIRN31 microRNA, humanhypoxiamesenchymal stem cellsmicroRNAsregenerative medicineRho family protein

Identifiers

PMID30925808
PMCPMC6480017
OpenAlexW2924804260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.